WYETH-AYERST's ANTIDEPRESSANT EFFEXOR WILL BE AVAILABLE IN EARLY SPRING; FIRM IS WORKING WITH FDA TO DEFINE CRITERIA FOR CLAIM OF RAPID ONSET OF ACTION
Executive Summary
Wyeth-Ayerst's dual-action antidepressant Effexor (venlafaxine) will be available in the U.S. in early spring as part of a global launch of the drug.